S&P 500   4,127.63 (-0.87%)
DOW   34,021.51 (-0.40%)
QQQ   305.33 (-1.47%)
AAPL   151.83 (-1.82%)
MSFT   268.55 (+0.37%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.21 (-2.84%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
S&P 500   4,127.63 (-0.87%)
DOW   34,021.51 (-0.40%)
QQQ   305.33 (-1.47%)
AAPL   151.83 (-1.82%)
MSFT   268.55 (+0.37%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.21 (-2.84%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
S&P 500   4,127.63 (-0.87%)
DOW   34,021.51 (-0.40%)
QQQ   305.33 (-1.47%)
AAPL   151.83 (-1.82%)
MSFT   268.55 (+0.37%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.21 (-2.84%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
S&P 500   4,127.63 (-0.87%)
DOW   34,021.51 (-0.40%)
QQQ   305.33 (-1.47%)
AAPL   151.83 (-1.82%)
MSFT   268.55 (+0.37%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.21 (-2.84%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
NASDAQ:MTP

Midatech Pharma - MTP Stock Forecast, Price & News

$0.74
-0.04 (-5.43%)
(As of 02/8/2023 12:14 PM ET)
Add
Compare
Today's Range
$0.73
$0.78
50-Day Range
$0.65
$1.69
52-Week Range
$0.60
$5.30
Volume
38,391 shs
Average Volume
63,311 shs
Market Capitalization
$15.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MTP stock logo

About Midatech Pharma (NASDAQ:MTP) Stock

Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Receive MTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Midatech Pharma and its competitors with MarketBeat's FREE daily newsletter.

MTP Stock News Headlines

BIOAF: Merger with Midatech Pharma
Huge Upside Potential With "Staggering" Solar Demand
Global solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth.
MTP Midatech Pharma plc
Midatech Pharma PLC Announces ADR Ratio Change
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Midatech Pharma PLC News
Midtech Booms on Discovery
Stock Alert: Midatech Pharma Jumps 40%
Midatech Pharma PLC Announces Business Update
See More Headlines
Receive MTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Midatech Pharma and its competitors with MarketBeat's FREE daily newsletter.

MTP Company Calendar

Today
2/08/2023
Next Earnings (Estimated)
4/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MTP
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$800,000.00
Book Value
$5.67 per share

Miscellaneous

Free Float
21,595,000
Market Cap
$15.93 million
Optionable
Not Optionable
Beta
2.23

Key Executives

  • Stephen Anthony Stamp
    Director, Chief Executive & Financial Officer
  • Dmitry Zamoryakhin
    Chief Scientific Officer
  • Dan Palmer
    Vice President-Technology
  • Steve Ellul
    Vice President-Business Development
  • Fiona Sharp
    Group Financial Controller













MTP Stock - Frequently Asked Questions

How have MTP shares performed in 2023?

Midatech Pharma's stock was trading at $0.9850 at the start of the year. Since then, MTP stock has decreased by 21.1% and is now trading at $0.7773.
View the best growth stocks for 2023 here
.

Are investors shorting Midatech Pharma?

Midatech Pharma saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 23,900 shares, a drop of 38.2% from the December 31st total of 38,700 shares. Based on an average daily trading volume, of 31,000 shares, the days-to-cover ratio is currently 0.8 days.
View Midatech Pharma's Short Interest
.

When is Midatech Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our MTP earnings forecast
.

When did Midatech Pharma's stock split?

Midatech Pharma's stock reverse split on the morning of Monday, September 26th 2022. The 1-5 reverse split was announced on Monday, September 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What other stocks do shareholders of Midatech Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include CRISPR Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Pfizer (PFE), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX), Plug Power (PLUG), SCYNEXIS (SCYX), Sangamo Therapeutics (SGMO) and Sorrento Therapeutics (SRNE).

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."

How do I buy shares of Midatech Pharma?

Shares of MTP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Midatech Pharma's stock price today?

One share of MTP stock can currently be purchased for approximately $0.78.

How much money does Midatech Pharma make?

Midatech Pharma (NASDAQ:MTP) has a market capitalization of $16.84 million and generates $800,000.00 in revenue each year.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA. The official website for the company is www.midatechpharma.com. The company can be reached via phone at 441235888300 or via email at ir@midatechpharma.com.

This page (NASDAQ:MTP) was last updated on 2/8/2023 by MarketBeat.com Staff